Press Trust of India | Last Updated: August 04, 2015 15:08 (IST)
Drug firm Ajanta Pharma has received final approvals from the US Food and Drug Administration (FDA) for generic montelukast tablets and oral granules used for prevention and treatment of asthma and to relieve symptoms of seasonal hay fever.
Press Trust of India | Last Updated: August 03, 2015 19:47 (IST)
Wockhardt is recalling over 50 lakh bottles of various drugs, used for treating ailments like high blood pressure and ulcer, in the US market due to deviations in current good manufacturing practice norms laid down by the US Food and Drug Administration.
Press Trust of India | Last Updated: August 02, 2015 18:16 (IST)
The new site, which represents up to Rs 1,000 crore in investments, will be the first greenfield pharma site GSK has built across the globe over the past 10 years.
Press Trust of India | Last Updated: August 01, 2015 13:01 (IST)
Sun Pharma Advanced Research Company (SPARC) on Saturday said the US Food and Drug Administration (FDA) has not approved its new drug application for anti-glaucoma eye drops.
Press Trust of India | Last Updated: July 30, 2015 23:35 (IST)
Sun Pharma, India's largest drug maker, may file application for a new drug with the US Food and Drug Administration in next two to three years, its managing director Dilip Shanghvi said on Thursday.
Press Trust of India | Last Updated: July 30, 2015 17:52 (IST)
Indoco Remedies Ltd on Thursday said it is looking at an investment of Rs 125 crore for expansion of its sterile ophthalmic facility at Goa and for setting up a green field API (active pharmaceutical ingredients) facility at Patalganga in Maharashtra.
Thomson Reuters | Last Updated: July 28, 2015 08:15 (IST)
India's Glenmark Pharmaceuticals' proposed generic version of Bayer AG's Finacea, a gel for treating the common skin condition rosacea, infringes Bayer's patent, a US court ruled on Monday.
Press Trust of India | Last Updated: July 27, 2015 22:01 (IST)
The company had posted a net profit of Rs 256 crore for the corresponding period of the previous fiscal, Torrent Pharmaceuticals said in a filing to the BSE.
Press Trust of India | Last Updated: July 27, 2015 17:02 (IST)
India's business loss arising from the European Union's ban on 700 generic drugs is likely to be around $1.2 billion, according to industry body Pharmexcil.
NDTV | Last Updated: July 27, 2015 15:51 (IST)
Allergan's generic business is generally seen as a better fit than Teva's previous target Mylan because it will improve Teva's distribution channels and because Allergan is strong in so-called biosimilar drugs.
Press Trust of India | Last Updated: July 26, 2015 16:16 (IST)
The government is reviewing the Drug (Prices Control) Order, 2013, to sort out implementation issues and make it more efficient - both for consumers and the industry.
Press Trust of India | Last Updated: July 25, 2015 17:19 (IST)
Cipla (EU), a wholly-owned subsidiary of the company, has re-negotiated the terms of the agreement and have entered into an amendment for upfront payment of the consideration amount instead of payment in tranches over a period of 5 years, the Mumbai-based company said in a statement.
Press Trust of India | Last Updated: July 25, 2015 17:12 (IST)
In a BSE filing, the Mumbai-based firm said shareholders have approved a proposal today "to raise funds for an amount not exceeding Rs 7,500 crore through issue of securities".
Press Trust of India | Last Updated: July 25, 2015 15:39 (IST)
The largest EU-wide suspension of sales and distribution of generic drugs ordered by the European Commission will come into effect on August 21 and it will be applicable to all 28 member nations, according to Germany's drug regulator, the Federal Institute for Medicines and Medical Products (BfArM).
Press Trust of India | Last Updated: July 23, 2015 19:59 (IST)
Drug firm Wockhardt, which has been under the scanner of the US Food and Drug Administration (FDA), on Thursday said that the American health regulator has completed inspection of its Nalagarh facility in Himachal Pradesh.
Thomson Reuters | Last Updated: July 23, 2015 15:35 (IST)
Lupin Ltd, India's third-largest drug maker by sales, is buying US peer GAVIS Pharmaceuticals LLC for $880 million (Rs 5,588 crore at $1 = Rs 63.5) in its largest ever acquisition, seeking to revive its flagging growth in the United States, its largest market.
Press Trust of India | Last Updated: July 21, 2015 12:27 (IST)
Earlier this month, the Cipla board approved divestment of its consumer healthcare business to a wholly-owned subsidiary which is yet to be incorporated, on a going-concern basis by way of a slump sale for a consideration of Rs 10.5 crore.
Press Trust of India | Last Updated: July 20, 2015 18:37 (IST)
The company has received establishment inspection report from the US Food and Drug Administration (USFDA) for the Barnala-based facility, IOLCP said in a filing to the BSE.
Thomson Reuters | Last Updated: July 20, 2015 17:59 (IST)
Sun Pharmaceutical Industries Ltd, India's largest drug maker, said on Monday that its revenue in fiscal year 2016 would be flat at best as it struggles to fix manufacturing problems at Ranbaxy Laboratories, which it bought last year.